Experience
Cumberland Pharmaceuticals
Mylan Institutional, LLC
In decisions from the U.S. Federal Circuit Court of Appeals, U.S. District Court for the Northern District of Illinois, and the American Arbitration Association (AAA), Finnegan successfully prevented a larger competitor from manufacturing or selling a generic version of Finnegan client Cumberland Pharmaceuticals’ flagship product, Acetadote®, a life-saving intravenous formulation of acetylcysteine for the treatment of acetaminophen overdose. Cumberland’s current patent-protected formulation is free of the EDTA chelating agent, which is an improvement over earlier formulations sold by Cumberland and others. First, in the AAA decision, the arbitrator issued a final award in favor of Cumberland enjoining the competitor and further awarded attorney’s fees and costs to Cumberland. Second, in the Abbreviated New Drug Application (ANDA) district court case, following claim construction rulings favorable to Cumberland, the generic company conceded infringement. A trial proceeded on the generic’s three validity attacks—derivation, anticipation, and obviousness—which were all rejected by the presiding judge. Finally, in response to the generic’s appeal of the district court’s decision, the Federal Circuit further considered and expressly rejected the generic’s validity attacks. The Federal Circuit’s affirmance of the district court’s ruling thus confirms Cumberland’s patent protection for ten years.
Cumberland Pharmaceuticals v. Mylan Institutional, LLC, 16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
Cumberland Pharmaceuticals v. Mylan Institutional, LLC, 1:12-cv-03846, N.D. Ill., Judge Pallmeyer
The Hillman Group, Inc. v. KeyMe, LLC
The Hillman Group, Inc.
Bright Data Ltd. v. NetNut Ltd.
NetNut Ltd.
Delta Faucet Company v. Globe Union Industrial Corp. et al.
Globe Union Industrial Corp.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
Eureka Database Solutions, LLC v. Nexidia, Inc.
Nexidia, Inc.
Guntert & Zimmerman Const. Div., Inc. v. GOMACO Corporation
GOMACO Corporation
Hawk Technology Systems, LLC v. Kirkland's Inc.
Kirkland's Inc.
Rondevoo Technologies, LLC v. RSIP Vision, Inc.
RSIP Vision, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.